Lamictal (Lamotrigine).
What It Does, the Titration Rule, and What to Expect.

Lamotrigine -- sold as Lamictal -- is a mood stabilizer and antiepileptic drug with a clinical profile that sets it apart from most psychiatric medications. It is well tolerated, does not cause weight gain, does not cause cognitive blunting, and has strong evidence for bipolar depression and maintenance. But it requires a titration schedule that is non-negotiable: going up too fast creates a real risk of a serious skin reaction. Understanding that rule is the foundation of using this medication safely.

What Is Lamictal?

Lamotrigine is a sodium channel blocker that stabilizes neuronal membranes and reduces the excessive firing of nerve cells. It also reduces the release of glutamate, an excitatory neurotransmitter that plays a role in both seizures and mood instability. It was originally developed as an anticonvulsant and has since become a mainstay of mood stabilizer treatment.

FDA-approved uses include:

• Epilepsy (multiple seizure types, as adjunct and monotherapy)
• Bipolar I disorder -- maintenance treatment to prevent recurrence of mood episodes
• Bipolar I disorder -- as an add-on to lithium or valproate

Widely used off-label for: bipolar II disorder, bipolar depression (it works better for preventing depressive than manic episodes), treatment-resistant depression as augmentation, and borderline personality disorder.

What Makes Lamictal Clinically Useful

Among mood stabilizers, lamotrigine has several properties that make it attractive:

• No weight gain. Unlike many psychiatric medications -- and unlike other mood stabilizers like valproate and lithium, which can cause significant weight gain -- lamotrigine is weight-neutral or associated with modest weight loss.
• No cognitive blunting. Many mood stabilizers, particularly lithium and valproate, cause cognitive dulling or memory issues. Lamotrigine generally does not. Some patients specifically choose lamotrigine to preserve cognitive clarity.
• Not sedating. Works without daytime sedation for most patients.
• Effective for bipolar depression. Bipolar depression is often undertreated -- antidepressants can trigger mania or cycling, and options are limited. Lamotrigine is one of the few medications with strong evidence for preventing depressive episodes in bipolar disorder.

The Titration Rule: Go Slow

The most important clinical fact about lamotrigine is that dose increases must follow a strict, gradual schedule. Rapid dose escalation significantly increases the risk of Stevens-Johnson Syndrome (SJS), a rare but potentially life-threatening immune reaction affecting the skin and mucous membranes.

Standard titration for adults (without interacting medications):

• Weeks 1 to 2: 25 mg once daily
• Weeks 3 to 4: 50 mg once daily
• Week 5: 100 mg daily
• Weeks 6 and beyond: increase by 50 mg every 1 to 2 weeks toward target
• Typical maintenance dose: 100 to 400 mg daily

Reaching a full therapeutic dose takes months, not weeks. Patients sometimes become frustrated with the pace, but it is genuinely important -- this is not excessive caution.

Critical Drug Interactions

Two drug interactions significantly change lamotrigine dosing requirements and require your prescriber to know about them:

• Valproate (Depakote) doubles lamotrigine levels. If you take both, the lamotrigine dose must be reduced -- typically to half of what it would otherwise be. The titration must also go even more slowly.
• Estrogen-containing birth control pills cut lamotrigine levels by roughly half. If you start, stop, or change a hormonal contraceptive while on lamotrigine, your levels will shift significantly. This can destabilize mood. Tell your prescriber if you make any changes to birth control.

Common Side Effects

• Headache -- common early on
• Dizziness
• Nausea -- taking with food helps
• Insomnia or vivid dreams -- some patients report this, especially early
• Rash -- see warning above; must be reported promptly

Once at a stable therapeutic dose, most patients find lamotrigine well tolerated. The side effect burden during steady-state is lower than for many other mood stabilizers.